These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9239629)

  • 1. Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog.
    Altschul M; Simpson KW; Dykes NL; Mauldin EA; Reubi JC; Cummings JF
    J Small Anim Pract; 1997 Jul; 38(7):286-91. PubMed ID: 9239629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine gastrinoma: a case study and literature review of therapeutic options.
    Hughes SM
    N Z Vet J; 2006 Oct; 54(5):242-7. PubMed ID: 17028663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
    Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
    J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Gastrin-Secreting Tumor With Sustained-Release Octreotide Acetate in a Dog.
    Kim S; Hosoya K; Takagi S; Okumura M
    J Am Anim Hosp Assoc; 2015; 51(6):407-12. PubMed ID: 26535461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of gastrinoma in a Shih-Tzu dog.
    Fukushima U; Sato M; Okano S; Aramaki Y; Ito H; Yoshioka K; Oyamada T; Uechi M
    J Vet Med Sci; 2004 Mar; 66(3):311-3. PubMed ID: 15107564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole in a dog with gastrinoma.
    Brooks D; Watson GL
    J Vet Intern Med; 1997; 11(6):379-81. PubMed ID: 9470166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of gastrinomas by nuclear medicine methods.
    Béhé M; Gotthardt M; Behr TM
    Wien Klin Wochenschr; 2007; 119(19-20):593-6. PubMed ID: 17985094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
    Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?
    Guarnotta V; Martini C; Davì MV; Pizza G; Colao A; Faggiano A;
    Endocrine; 2018 Apr; 60(1):15-27. PubMed ID: 29019150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment.
    Shi W; Buchanan KD; Johnston CF; Larkin C; Ong YL; Ferguson R; Laird J
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):303-9. PubMed ID: 9578820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor imaging in vivo by planar scintigraphy facilitates the diagnosis of canine insulinomas.
    Garden OA; Reubi JC; Dykes NL; Yeager AE; McDonough SP; Simpson KW
    J Vet Intern Med; 2005; 19(2):168-76. PubMed ID: 15822560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease.
    Krassas GE; Doumas A; Kaltsas T; Halkias A; Pontikides N
    Thyroid; 1999 Jan; 9(1):47-52. PubMed ID: 10037076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide in control of multiple liver metastases from gastrinoma.
    Saijo F; Naito H; Funayama Y; Fukushima K; Shibata C; Hashimoto A; Kitayama T; Nagao M; Matsuno S; Sasaki I
    J Gastroenterol; 2003; 38(9):905-8. PubMed ID: 14564638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours.
    Angeletti S; Corleto VD; Schillaci O; Marignani M; Annibale B; Moretti A; Silecchia G; Scopinaro F; Basso N; Bordi C; Delle Fave G
    Gut; 1998 Jun; 42(6):792-4. PubMed ID: 9691916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of a large malignant gastrinoma on treatment with Sandostatin LAR: a case report.
    Granberg D; Jacobsson H; Oberg K; Gustavsson J; Lehtihet M
    Digestion; 2008; 77(2):92-5. PubMed ID: 18376130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analogue (SMS 201-995) in patients with gastrinomas.
    Vinik AI; Tsai S; Moattari AR; Cheung P
    Surgery; 1988 Nov; 104(5):834-42. PubMed ID: 2903562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new concept of therapeutic strategy for neuroendocrine tumors: important information from a case report of gastrinoma.
    Igarashi H; Ito T; Takayanagi R
    Intern Med; 2010; 49(17):1839-40. PubMed ID: 20823641
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastrinoma: a retrospective study of four cases (1985-1995).
    Green RA; Gartrell CL
    J Am Anim Hosp Assoc; 1997; 33(6):524-7. PubMed ID: 9358421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.